Mitral Regurgitation
A condition in which the mitral valve does not close completely during contraction of the left ventricle, causing blood to leak backward into the left atrium.
Aortic Stenosis
A narrowing of the aortic valve, which reduces or blocks blood flow from the left ventricle to the aorta.
Stroke Risk Reduction
Interventions to prevent thrombus formation include percutaneous closure of the left atrial appendage (LAA) and the patent foramen ovale (PFO).
Congenital defects
Congenital heart defects can involve the walls of the heart, the heart valves, and arteries and veins near the heart, disrupting normal blood flow.
Every Heart has a Story
The testimonials relate to accounts of individuals’ responses to treatments. The patients’ accounts are genuine, typical and documented. However, it does not provide any indication, guide, warranty, or guarantee as to the response other persons may have to the treatment. Responses to the treatment discussed can and do vary and are specific to the individual patient.
MAT-2000633 to v3.0 | Item approved for Global OUS use only.
- Feldman T, et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol. 2015;66:2844–54) © 2015 by the American College of Cardiology Foundation.
- Kar S, Whitlow P, Pedersen W, et al. Effectiveness of transcatheter reduction of significant mitral regurgitation in high surgical risk patients with MitraClip: final 5-year results of the EVEREST II High Risk Registry presented at ACC 2014; March 29, 2014; Washington, DC.
- Sorajja P, et al. Initial experience with commercial transcatheter mitral valve repair in the United States. J Am Coll Cardiol. 2016;67(10):1129-1140.
- Ailawadi G. Updated MitraClip outcomes from the STS TVT Registry. On behalf of the TVT Registry. May 5, 2016.
- Data on file at Abbott.
- Saver JL, Carroll JD, Thaler DE, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med. 2017; 377: 1022-32.